Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hodgson

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 17, 2024
Radiation Dose-Volume-Response Relationships for Adverse Events in Childhood Cancer Survivors: Introduction to the Scientific Issues in PENTECSøren M Bentzen, Ivan R Vogelius, David Hodgson, et al.
Implementation Science : IS|February 23, 2024
Protocol for the ONLOOP trial: pragmatic randomized trial evaluating a province-wide system of personalized reminders for evidence-based surveillance tests in adult survivors of childhood cancer in OntarioJennifer Shuldiner, Emily Lam, Nida Shah, et al.
JAMA Oncology|January 2, 2025
Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical TrialBradford S Hoppe, Sarah A Milgrom, Lindsay A Renfro, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin LymphomaXin Tie, Sarah A Milgrom, Andrea C Lo, et al.
Advances in Radiation Oncology|April 28, 2025
Outcomes of Primary Mediastinal B-cell Lymphoma Patients with Partial Metabolic Response: A Multicenter Retrospective AnalysisNattinee Wattakiyanon, Mahmood Aminilari, Xiang Y Ye, et al.
Blood|June 28, 2022
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysisAkash Parekh, Frank G Keller, Kathleen M McCarten, et al.
Practical Radiation Oncology|March 1, 2026
Management and Outcomes for Hodgkin's Lymphoma Patients with Partial Metabolic Response after First-Line Systemic TherapyDonna Liao, Mahmood Aminilari, Xiang Y Ye, et al.
International Journal of Particle Therapy|February 7, 2022
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin LymphomaRaymond B Mailhot Vega, Sharon M Castellino, Qinglin Pei, et al.
American Journal of Hematology|February 16, 2022
Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volumeHo-Young Yhim, Yael Eshet, Ur Metser, et al.
The Lancet. Haematology|December 31, 2021
Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trialsJustine M Kahn, Qinglin Pei, Debra L Friedman, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
International Journal of Radiation Oncology, Biology, Physics|May 17, 2024
Radiation Dose-Volume-Response Relationships for Adverse Events in Childhood Cancer Survivors: Introduction to the Scientific Issues in PENTECSøren M Bentzen, Ivan R Vogelius, David Hodgson, et al.
Implementation Science : IS|February 23, 2024
Protocol for the ONLOOP trial: pragmatic randomized trial evaluating a province-wide system of personalized reminders for evidence-based surveillance tests in adult survivors of childhood cancer in OntarioJennifer Shuldiner, Emily Lam, Nida Shah, et al.
JAMA Oncology|January 2, 2025
Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical TrialBradford S Hoppe, Sarah A Milgrom, Lindsay A Renfro, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin LymphomaXin Tie, Sarah A Milgrom, Andrea C Lo, et al.
Advances in Radiation Oncology|April 28, 2025
Outcomes of Primary Mediastinal B-cell Lymphoma Patients with Partial Metabolic Response: A Multicenter Retrospective AnalysisNattinee Wattakiyanon, Mahmood Aminilari, Xiang Y Ye, et al.
Blood|June 28, 2022
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysisAkash Parekh, Frank G Keller, Kathleen M McCarten, et al.
Practical Radiation Oncology|March 1, 2026
Management and Outcomes for Hodgkin's Lymphoma Patients with Partial Metabolic Response after First-Line Systemic TherapyDonna Liao, Mahmood Aminilari, Xiang Y Ye, et al.
International Journal of Particle Therapy|February 7, 2022
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin LymphomaRaymond B Mailhot Vega, Sharon M Castellino, Qinglin Pei, et al.
American Journal of Hematology|February 16, 2022
Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volumeHo-Young Yhim, Yael Eshet, Ur Metser, et al.
The Lancet. Haematology|December 31, 2021
Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trialsJustine M Kahn, Qinglin Pei, Debra L Friedman, et al.
Pageof 18